EXMceuticalsPortugal

EXMceuticals Portugal Lda is a biopharmaceutical company focused on utilising phytochemicals, with a scientific and evidential basis, for therapeutic use to benefit patients and consumers worldwide in the areas of healthcare and wellness.

EXMceuticals Portugal Lda’s laboratory has been awarded two grants by the European Union and the Portuguese Government in the areas of COVID-19 and topical cosmeceutical cannabinoid and terpene applications, as follows:

BioBlock COVID: A Consortium led by EXMceuticals Portugal Lda, operating under the Project name "BioBlock COVID" and consisting of EXMceuticals Portugal Lda, Cosmetek Lda, and the Universidade de Coimbra has been awarded a grant by the European Regional Development Fund and the Portuguese Government to study further and develop disinfectants to combat SARS -CoV-2, the virus that causes COVID-19. The BioBlockCOVID project aims to create functional, natural and innovative biocide formulations that will specifically target and block the molecules that promotes COVID-19. The research will focus on the virucide and antiviral action of naturally occurring bioactive compounds from the cannabis and wild plants.

SkanABility: A Consortium led by EXMceuticals Portugal Lda, operating under the Project name “SkanABility” and consisting of EXMceuticals Portugal Lda and COSMETEK Lda, VINIDEAS, Faculdade de Farmácia-Universidade de Lisboa, Universidade do Minho, COFAC-Universidade Lusófona, Estado Maior do Exército has been awarded a grant by the European Union and the Portuguese Government.